Back to everyone

Craig Fox

Operating Partner, Life Sciences

Craig Fox

Craig joined Oxford Science Enterprises in February 2022, bringing over 20 years of drug discovery and development expertise, with vast experience as a research scientist managing initial target selection through to Phase 2 clinical studies.

At OSE, Craig supports the growth and development of Life Science businesses, the identification of new opportunities, and formation of new spinouts.

He joined from C4X Discovery where he was Chief Scientific Officer and an Executive Board Member for more than six years, guiding its transition from a technology-based company to a therapeutics business. Craig has also worked at a number of biotechnology companies supporting multiple financing deals, the creation and management of strategic collaborations and licensing deals with Pharma.

Craig holds a PhD in Respiratory Medicine from Birmingham University and a first-class Biochemistry degree from the University of Surrey.

Craig sits on the board of

  • EndLyz
  • Human Centric Drug Discovery
  • Kesmalea

Meet everyone in the

Life Sciences Team

Chris Ashton
Chris AshtonAdvisor
Claire Brown
Claire BrownPartner, Life Sciences
Jon Hepple
Jon HeppleAdvisor
Katya Smirnyagina
Katya SmirnyaginaSenior Partner, Life Sciences
Phil Jakeman
Phil JakemanScientist in Residence, Life Sciences
Sally Dewhurst
Sally DewhurstSenior Associate, Life Sciences
Wallace Wallace
Wallace WallaceAssociate, Life Sciences